89 min listen
Episode 92 | Nick Accordino and Will Braeutigam: Deloitte | Taking your Medtech Company Public: SPACs vs. IPOs
FromProject Medtech
Episode 92 | Nick Accordino and Will Braeutigam: Deloitte | Taking your Medtech Company Public: SPACs vs. IPOs
FromProject Medtech
ratings:
Length:
69 minutes
Released:
May 9, 2022
Format:
Podcast episode
Description
In this episode, Nick Accordino and Will Braeutigam from Deloitte and Duane Mancini discuss discuss SPACs, what are SPACs, why would a company want to go public, the differences in going public through an IPO vs. SPAC, strategic acquisition vs. going public, the myths of going public via a SPAC, preparing your company to go public, and so much more.
Nick Accordino LinkedIn
Will Braeutigam LinkedIn
Deloitte Website
Project Medtech Website
Duane Mancini LinkedIn
Project Medtech LinkedIn
Released:
May 9, 2022
Format:
Podcast episode
Titles in the series (100)
Medtech Money --- Episode 1: Brian Greene, CTO at HMD Labs --- Leaving Corporate to become a Medtech Founder by Project Medtech